Veterinary Medicines

Addimag VRIJ 240 mg/ml + 126 mg/ml oplossing voor infusie voor runderen

Authorised
  • Calcium gluconate monohydrate
  • Magnesium chloride hexahydrate
Download as PDF

Product identification

Medicine name:
Addimag VRIJ 240 mg/ml + 126 mg/ml oplossing voor infusie voor runderen
Active substance:
  • Calcium gluconate monohydrate
  • Magnesium chloride hexahydrate
Target species:
  • Cattle
Route of administration:
  • Intravenous use
  • Intravenous use

Product details

Active substance and strength:
  • Calcium gluconate monohydrate
    240.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Magnesium chloride hexahydrate
    126.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for infusion
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Meat and offal
        no withdrawal period
  • Intravenous use
    • Cattle
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12AX
Legal status of supply:
  • Medicinal product not subject to medical prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • Alfasan Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfasan Nederland B.V.
  • Bela-Pharm GmbH & Co. KG
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 130342
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 10/10/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."